Temete Healthcare Corporation (Nyse:TH) Q2 2025 Conference Conference Conference July 22, 2025 10:00 AM
Company participants
William McDowell – Vice President of Investor Relations
Saumya Sutaria – Chairman & CEO
Sun Park – Executive VP & CFO
Conference participants
Albert Rice – UBS Investment Bank, Research Division
Joshua Raskin – Nephron Research LLC
Andrew Mok – Barclays Bank PLC, Research Division
Matthew Gillmor – Keybanc Capital Markets Inc., Research Division
Justin Lake – Wolfe Research, LLC
Sarah James – Cantor Fitzgerald & Co., Division in Research
Stephen Baxter – Wells Fargo Securities, LLC, Research Division
Benjamin Hendrix – RBC capital markets, research division
Benjamin Mayo – Leerink Partners LLC, Division of Research
Seven Fickeing – Deutsche Bank AG, Resiord Divition
Benjamin Rossi – Jpmorgan Chase & Co., Research Division
Ryan Langston – TD Cowen, Research Division
Juan Ransom – Raymond James & Associates, Inc., Research Division
Kevin Fischbeck – Bofa Securities, Research Division
Operator
Good morning. Welcome to Teet Healthcare Second Quarters 2025 Income Conference Call. (Operator instructions)
I will now make your host’s call, Mr. McDowewell, Vice President of investor relationships. McDowell, you can start.
William McDowell
Good morning, all, thanks for calling now to call now. I am McDowell, Vice President of investor relationships. We are glad to join us for a discussion of the second quarter of Teet 2025 as well as a discussion of financial views.
The senior management of the teet participated in the call today is Sumya Sutaria, chairman and chief ebekuti official; and Sun, Executive Vice President and Chief Financial Officer.
Our webcast this morning includes a slide presentation, posted in the investor’s relationship section on our website, tenethalth.com. The listeners of this call are advised that some statements performed in our discussion currently expected and represented the management’s
